In This Article:
PASADENA, Calif. (AP) — PASADENA, Calif. (AP) — Xencor Inc. (XNCR) on Wednesday reported a loss of $48.4 million in its first quarter.
The Pasadena, California-based company said it had a loss of 66 cents per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The biotech developing antibodies for severe autoimmune/allergic diseases and cancer posted revenue of $32.7 million in the period, which beat Street forecasts. Six analysts surveyed by Zacks expected $22.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XNCR at https://www.zacks.com/ap/XNCR